Reports for LAMIVUDINE
Ingredient
LAMIVUDINE
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ABACAVIR-LAMIVUDINE | 600MG 300MG | TABLET | Resolved | 2019-01-03 | 2019-01-23 | 71098 |
APO-ABACAVIR-LAMIVUDINE | 600MG 300MG | TABLET | Resolved | 2019-04-22 | 2019-07-29 | 82102 |
APO-ABACAVIR-LAMIVUDINE | 600MG 300MG | TABLET | Resolved | 2019-08-21 | 2020-01-27 | 92016 |
PMS-ABACAVIR-LAMIVUDINE | 600MG 300MG | TABLET | Resolved | 2017-10-12 | 2018-10-03 | 25829 |
PMS-ABACAVIR-LAMIVUDINE | 600MG 300MG | TABLET | Resolved | 2018-02-06 | 2018-08-24 | 38860 |
PMS-ABACAVIR-LAMIVUDINE | 600MG 300MG | TABLET | Resolved | 2019-03-04 | 2022-06-23 | 77526 |
PMS-ABACAVIR-LAMIVUDINE | 600MG 300MG | TABLET | Resolved | 2019-03-04 | 2022-06-23 | 77531 |
KIVEXA | 600MG 300MG | TABLET | Resolved | 2019-01-30 | 2019-03-15 | 74011 |
APO-LAMIVUDINE HBV | 100MG | TABLET | Resolved | 2019-12-05 | 2020-02-25 | 100278 |
APO-LAMIVUDINE HBV | 100MG | TABLET | Resolved | 2021-05-07 | 2021-06-28 | 138957 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
HEPTOVIR | 5MG | SOLUTION | Discontinued | 2022-05-13 | 2022-07-22 | 160503 |
APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |
APO-LAMIVUDINE | 300MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60560 |
APO-LAMIVUDINE HBV | 100MG | TABLET | Discontinued | 2018-09-07 | 2019-12-21 | 60563 |
HEPTOVIR | 100MG | TABLET | Discontinued | 2022-05-13 | 2022-08-10 | 160500 |
TRIZIVIR | 300MG 300MG 150MG | TABLET | Discontinued | 2019-09-18 | 2019-09-18 | 94278 |
TEVA-LAMIVUDINE/ZIDOVUDINE | 300MG 150MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104260 |
APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE | 300MG 150MG 300MG | TABLET | Discontinued | 2022-12-12 | 2022-12-12 | 177953 |
Showing 1 to 8 of 8